iVeena Delivery Systems, Inc. ("iVeena"), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today announced that the first participant has ...

The Casppian study design included periodic evaluations and long-term safety monitoring for up to a total of 12 months following the first injection. -- There has been no safety concern with the use ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy for the acute treatment ...

Does it only affect weak people? Is work always the cause? Burnout myths, busted by the experts ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI ...

Zydus on Friday said U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to Desidustat for the treatment of Sickle Cell Disease (SCD).

Hua Medicine is developing potentially disease-modifying therapeutics for type 2 diabetes, driven by mechanisms in the glucose homeostasis process. Having launched dorzagliatin in China in 2022, the ...

Once upon a time, in a cave just north of Durango, Mexico, someone took a poop. In fact, it was quite a few someones, and these events were spread out over quite a bit of time—from about 725 A.D. to ...

AASA’s advocacy team has many great sessions planned for NCE to discuss how federal actions are impacting local districts.

The Federal College of Education, Abeokuta, on Friday announced the commencement of its independent degree-awarding programmes, marking the end of its affiliation with other universities for degree ...